BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19841465)

  • 1. Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.
    Lin HJ; Hsu YC
    Ann Intern Med; 2009 Oct; 151(8):589; author reply 590. PubMed ID: 19841465
    [No Abstract]   [Full Text] [Related]  

  • 2. Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.
    Yih V; Tejani A
    Ann Intern Med; 2009 Oct; 151(8):588-9; author reply 590. PubMed ID: 19841463
    [No Abstract]   [Full Text] [Related]  

  • 3. Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.
    Piscoya A
    Ann Intern Med; 2009 Oct; 151(8):589-90; author reply 590. PubMed ID: 19841464
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial.
    Chiu PW; Joeng HK; Choi CL; Tsoi KK; Kwong KH; Lam SH; Sung JJ
    Endoscopy; 2016 Aug; 48(8):717-22. PubMed ID: 27275859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.
    Yen HH; Yang CW; Su WW; Soon MS; Wu SS; Lin HJ
    BMC Gastroenterol; 2012 Jun; 12():66. PubMed ID: 22681960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton-pump inhibitors in peptic ulcer disease.
    Chan FK
    Lancet; 2008 Oct; 372(9645):1198-200. PubMed ID: 19094939
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.
    Tan VP; Wong BC
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1157-8. PubMed ID: 19682187
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.
    Tsai JJ; Lin HJ
    Gastrointest Endosc; 2010 Jul; 72(1):223-4; author reply 224-5. PubMed ID: 20620284
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
    Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan?
    Chan FK
    J Gastroenterol Hepatol; 2010 Jan; 25(1):6-7. PubMed ID: 20136970
    [No Abstract]   [Full Text] [Related]  

  • 14. It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
    Barkun AN; Kuipers EJ; Sung JJ
    Am J Gastroenterol; 2009 Aug; 104(8):2120-1. PubMed ID: 19661947
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
    Sung JJ; Barkun A; Kuipers EJ; Mössner J; Jensen DM; Stuart R; Lau JY; Ahlbom H; Kilhamn J; Lind T;
    Ann Intern Med; 2009 Apr; 150(7):455-64. PubMed ID: 19221370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the era of intravenous proton pump inhibitors coming to an end in patients with bleeding peptic ulcers? Meta-analysis of the published literature.
    Jian Z; Li H; Race NS; Ma T; Jin H; Yin Z
    Br J Clin Pharmacol; 2016 Sep; 82(3):880-9. PubMed ID: 26679691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitor for peptic ulcer bleeding.
    Zullo A; Hassan C; Morini S
    Aliment Pharmacol Ther; 2005 Nov; 22(9):891-2; author reply 892. PubMed ID: 16225502
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bleeding ulcers: prevention of relapse: continuous PPI use no better than intermittent].
    Escher M
    Dtsch Med Wochenschr; 2015 Jan; 140(1):14. PubMed ID: 25580963
    [No Abstract]   [Full Text] [Related]  

  • 20. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
    Lin HJ; Tsai JJ
    Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.